FrançaisAbbVie vs Johnson & Johnson: which stock to buy?
Head to head
| Metric | AbbVie | Johnson & Johnson | Edge |
|---|---|---|---|
| Price | $258 | $266 | |
| Median target (12m) | $282 (+9%) | $280 (+5%) | |
| Analyst reliability (1y) | 50% | 24% | 🟢 ABBV |
| Avg gain / call (1y) | +15% | +10% | |
| P/E | 74.0 | 30.9 | 🔵 JNJ |
| $1000 invested (10y ago) | $4,248 | $2,472 | 🟢 ABBV |
Performance by year
| Year | ABBV | JNJ | Winner |
|---|---|---|---|
| 2026 | +10% | +23% | 🔵 JNJ |
| 2025 | +29% | +43% | 🔵 JNJ |
| 2024 | +15% | -8% | 🟢 ABBV |
| 2023 | -4% | -11% | 🟢 ABBV |
| 2022 | +19% | +3% | 🟢 ABBV |
| 2021 | +26% | +9% | 🟢 ABBV |
| 2020 | +21% | +8% | 🟢 ABBV |
| 2019 | -4% | +13% | 🔵 JNJ |
| 2018 | -5% | -8% | 🟢 ABBV |
| 2017 | +54% | +21% | 🟢 ABBV |
| 2016 | +6% | +12% | 🔵 JNJ |
Frequently asked questions
AbbVie or Johnson & Johnson: which to buy?
Over ~10 years, AbbVie returned $4,248 on $1000 vs $2,472 for Johnson & Johnson, and AbbVie has better analyst reliability. Not advice: also check valuation (P/E) and your horizon.
AbbVie vs Johnson & Johnson: which performed best?
Over ~10 years, AbbVie wins ($4,248 vs $2,472 on $1000 invested, price return excluding dividends).
AbbVie vs Johnson & Johnson: which is cheaper?
On P/E, Johnson & Johnson is cheaper (74.0 vs 30.9). A lower P/E isn't always a better deal (growth matters).
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Past price performance (excluding dividends). Data: Yahoo Finance.